• °íȯ¿¡ ¹ß»ýÇÑ ¸ð¼¼Ç÷°ü¼º Ç÷°üÁ¾

• Capillary Hemangioma of the Testis

• ¹ÚÀÓÂù/Im Chan Park

• ¾çÀÌö/¹Ú¼º¿î/¹ÚÃá¼ö/¿À±æÇö/À̱¤¹Î/Lee Cheol Yang/Seong Woon Park/Chun Su Park/Kil Hyun Oh/Kwang Min Lee

• ´ëÇѺñ´¢±â°úÇÐȸÁö   2001³â  42±Ç  8È£  886 ~ 888

• °íȯ¿¡ ¹ß»ýÇÑ Sparganosis

• Sparganosis in the Testis

• ±è´ë¼º/Dae Seong Kim

• ¹ÚÇöÁØ/±è¼º¿ë/±è¼±ÀÏ/ÀÌÃá¿ë/¹Ú¹®Çâ/Hyun Jun Park/Seong Yong Kim/Sun Il Kim/Tchun Yong Lee/Moon Hyang Park

• ´ëÇѺñ´¢±â°úÇÐȸÁö   2001³â  42±Ç  8È£  883 ~ 885

• ¿ä°ü¿¡ ¹ß»ýÇÑ ¿ø¹ß¼º ÆíÆò»óÇǾÏ

• Primary Squamous Cell Carcinoma of the Ureter

• ±è¼¼¿õ/Sae Woong Kim

• ÀÌÁö¿­/À̽ÂÁÖ/¹Ú¿ÕÁø/°íÁؼº/Á¶¿ëÇö/À±¹®¼ö/À̱³¿µ/Ji Youl Lee/Seung-Ju Lee/Wang Jin Park/Jun Sung Ko/Yong-Hyun Cho/Moon Soo Yoon/Kyo-Young Lee

• ´ëÇѺñ´¢±â°úÇÐȸÁö   2001³â  42±Ç  8È£  879 ~ 882

• ÀÜÁ¸¿ä°ü°ú ¹æ±¤¿¡ ÀüÀÌµÈ ½Å¼¼Æ÷¾Ï

• Metastases to Ureteral Stump and Bladder from Renal Cell Carcinoma

• °­µ¿±¸/Dong Goo Kang

• ³²Àç±Ù/°­Á¤¼ö/¾çÈñŹ/Á¤È£Çö/ÃÖ³«±Ô/Jae Geun Nam/Jung Soo Kang/Hee Tak Yang/Ho Hyeon Jung/Nak Gyeu Choi

• ´ëÇѺñ´¢±â°úÇÐȸÁö   2001³â  42±Ç  8È£  875 ~ 878

• EstrogenÀÌ ÈòÁã ½ÅÀÇ ¼ö»êÄ®½· ħÂø¿¡ ¹ÌÄ¡´Â ¿µÇâ

• The Effects of Estrogen on Calcium Oxalate Crystal Deposition in Rat Kidney

• õ¹Î¿ì/Min Woo Cheon

• ±è¿µ°ï/Young Gon Kim

• ´ëÇѺñ´¢±â°úÇÐȸÁö   2001³â  42±Ç  8È£  870 ~ 874

• ¿¬°ñ¼¼Æ÷¿Í ÁßÇÕü·Î Á¦ÀÛÇÑ ¿¬°ñÁ¶Á÷: À½°æ¼ºÇü »ðÀÔ¹°Áú·ÎÀÇ ÀÀ¿ëÀ» À§ÇÑ ±âÃÊ¿¬±¸

• Engineered Tissue for Augmentation Penoplasty Using Chondrocytes and Biodegradable Polymers

• ¹ÚÈïÀç

• ±ÇÄ¥ÈÆ

• ´ëÇѺñ´¢±â°úÇÐȸÁö   2001³â  42±Ç  8È£  864 ~ 869

• ºó´¢-ºÒ¾È ÁõÈıºÀÇ ÀÓ»óÀû Ư¼º

• Clinical Characteristics of Frequency-Anxiety Syndrome

• ±èµÎÈ«

• ±ÇÇ念

• ´ëÇѺñ´¢±â°úÇÐȸÁö   2001³â  42±Ç  8È£  858 ~ 863

• ¸¸¼º °ñ¹Ýµ¿ÅëÁõÈıº ȯÀÚ¿¡¼­ ¿äõÃߺΠ°ñ°Ý±âÇüÀÇ ºóµµ

• The Incidence of Lumbosacral Bony Deformities in Patients with Chronic Pelvic Pain Syndrome

• ±èÁظð/Jun Mo Kim

• ±è¿µÈ£/¼ÛÀ±¼·/±è¹ÎÀÇ/À̳²±Ô/¹Ú¿µÈ£/Young Ho Kim/Yoon Seob Song/Min Eui Kim/Nam Kyu Lee/Young Ho Park

• ´ëÇѺñ´¢±â°úÇÐȸÁö   2001³â  42±Ç  8È£  855 ~ 857

• Ç¥ÇǼºÀåÀÎÀÚ, ¿°±â¼º ¼¶À¯¸ð¼¼Æ÷ ¼ºÀåÀÎÀÚ ¹× °¢Áú¼¼Æ÷ ¼ºÀåÀÎÀÚ°¡ LNCaP Àü¸³¼±¾Ï ¼¼Æ÷ÁÖÀÇ PSA ºÐºñ¿Í P...

• Effects of Epidermal Growth Factor, Basic Fibroblast Growth Factor and Keratinocyte Growth Factor on...

• ÇÑ»óÀÍ

• À̱ټ®, ¹éÀÎÈ£, ±è¿µ±Õ

• ´ëÇѺñ´¢±â°úÇÐȸÁö   2001³â  42±Ç  8È£  849 ~ 854

• ¼­¿ï Áö¿ª 40¼¼ ÀÌ»óÀÇ ³²¼ºÀ» ´ë»óÀ¸·Î ÇÑ ÇϺοä·ÎÁõ»ó¿¡ ´ëÇÑ ¿ªÇÐÁ¶»ç

• Epidemiologic Survey Using International Prostate Symptom Score (I-PSS) of Lower Urinary Tract Sympt...

• Á¶±Ô¼±/Kyu Seon Cho

• Á¶¹®±â/ÀÓ´ëÁ¤/¼Õȯö/±èÇöȸ/ÀÌÁ¾¿í/¹Ú¼ö°æ/À¯±Ù¿µ/Moon Ki Jo/Daejung Lim/Hwancheol Son/Hyeon Hoe Kim/Chongwook Lee/Sue Kyung Park/Keun-Young Yoo

• ´ëÇѺñ´¢±â°úÇÐȸÁö   2001³â  42±Ç  8È£  840 ~ 848

• ¿¬·Éº° Àü¸³¼±Æ¯ÀÌÇ׿øÀÇ Á¤»ó Âü°íÄ¡: °æ»ó³²µµ ³²Çرº Áö¿ª ¿ªÇÐÀû Á¶»ç

• Age-Specific Reference Ranges for Serum Prostate-Specific Antigen: Community-based Survey in Namhae ...

• ÃÖ¿µµæ/Young Deuk Choi

• È«¼ºÁØ/³ª±ºÈ£/Â÷°æºó/¸¶»ó¿­/À̹«»ó/¼ÛÀç¼®/ÃÖÁ¾¶ô/±èÇö¼÷/±èºÀȯ/Sung Jun Hong/Koon Ho Rha/Kyung Bin Cha/Sang Yol Mah/Moo Sang Lee/Jae Suk Song/Jong Rak Choi/Hyun Sook Kim/Bong Hwan ...

• ´ëÇѺñ´¢±â°úÇÐȸÁö   2001³â  42±Ç  8È£  834 ~ 839

• Àü¸³¼±¾Ï¿¡¼­ p53, bcl-2 ´Ü¹éÀÇ ¹ßÇö ¹× Ki-67 Ç¥ÁöÁö¼ö¿Í ¿¹ÈÄÀÎÀÚ¿ÍÀÇ »ó°ü °ü°è

• Expressions of p53, bcl-2 Protein and Ki-67 Labelling Index and Their Relationships with Prognostic ...

• ±è´ë°ï/Dae Gon Kim

• ÀÌ°æ¼·/±è±â±Ç/Kyung Seop Lee/Ki Kwon Kim

• ´ëÇѺñ´¢±â°úÇÐȸÁö   2001³â  42±Ç  8È£  828 ~ 833

• ±ÙÄ¡Àû Ä¡·á Àü º´¸®ÇÐÀû º´±â ¼³Á¤ÀÇ ¿¹ÃøÀÎÀڷμ­ Àü¸³¼±¾Ï¿ëÀû¿¹ÃøÄ¡ÀÇ ÀÓ»óÀû À¯¿ë¼º

• Clinical Significance of Calculated Prostate Cancer Volume as the Predictor of Pathologic Stage

• ÀÌ°æ·¡

• õÁØ

• ´ëÇѺñ´¢±â°úÇÐȸÁö   2001³â  42±Ç  8È£  821 ~ 827

• Ç÷û Àü¸³¼±Æ¯ÀÌÇ׿øÀÌ 4-10ng/mlÀΠȯÀÚ¿¡¼­ À¯¸®Çü Àü¸³¼±Æ¯ÀÌÇ׿ø ºñÀ²ÀÌ Àü¸³¼±¾Ï ¹ß°ßÀ²¿¡ ¹ÌÄ¡´Â ¿µ...

• The Effectiveness of Free/Total Prostate Specific Antigen (PSA) Ratio for Increasing the Detection R...

• ÀÌ»óÀç

• ¼­ÀÏ¿µ, ±èÁ¾¼º, ±èâ±Ù

• ´ëÇѺñ´¢±â°úÇÐȸÁö   2001³â  42±Ç  8È£  815 ~ 820

• Àü¸³¼±ºñ´ëÁõÀÇ Æò°¡¿¡ À־ ¿ä¿ªµ¿Çа˻ç¿Í Àü¸³¼±¿ëÀûÁöÇ¥ÀÇ »ó°ü¼º

• The Correlation of Urodynamic Study with Prostate Volume Parameters in the Evaluation of the BPH

• °í¿µ¼ö

• ÀÌÁ¤±¸

• ´ëÇѺñ´¢±â°úÇÐȸÁö   2001³â  42±Ç  8È£  809 ~ 814

• Àü¸³¼±ºñ´ëÁõ ȯÀÚ¿¡¼­ °æ¿äµµÀü¸³¼±Àü±â±âÈ­¼úÀÇ Ä¡·á È¿°ú

• Clinical Results of Transurethral Electro-Vaporization of the Prostate for Treatment of Benign Prost...

• ÀÌÈ£°ï

• ¹Ú¿ëÀÏ, Á¶¼º·æ

• ´ëÇѺñ´¢±â°úÇÐȸÁö   2001³â  42±Ç  8È£  804 ~ 807

• ±Þ¼º Àü¸³¼±¿°ÀÇ Áø´Ü ¹× ÃßÀû°Ë»ç¿¡¼­ Ç÷û Àü¸³¼±Æ¯ÀÌÇ׿øÀÇ À¯¿ë¼º

• The Value of Serum Prostate-specific Antigen in the Diagnosis and Follow-up of Acute Prostatitis

• ÀÌÁØ¿±/Jun Yoep Lee

• ±è¼¼Áß/¾ÈÇö¼ö/Se Joong Kim/Hyun Soo Ahn

• ´ëÇѺñ´¢±â°úÇÐȸÁö   2001³â  42±Ç  8È£  800 ~ 803

• ¿ä°ü°æÇÏ ¹è¼®¼ú: È¿¿ë¼º°ú ¾ÈÀü¼º ¹× ½Ã¼úÀÚÀÇ ¼÷·Ãµµ

• Ureteroscopic Stone Removal: Efficacy, Safety and Skilled Experience of the Surgeon

• ±èÁØ¿ë

• ½ÉºÀ¼®

• ´ëÇѺñ´¢±â°úÇÐȸÁö   2001³â  42±Ç  8È£  795 ~ 799

• ½Å¼¼Æ÷¾Ï¿¡¼­ Microsatellite ºÎÀ§ °Ô³ðÀÇ ºÒ¾ÈÁ¤¼º

• Gnomic Instability of Microsatellite in Renal Cell Carcinoma

• Á¶Á¦Çå/Jae Hun Cho

• ±ÇűÕ/±æ¿µÅÂ/¹ÚÀ±±Ô/Á¤¿îº¹/±èÁ¤¿Ï/Tae Gyun Kwon/Young Tae Gil/Yoon Kyu Park/Oon Bok Jung/Jung Wan Kim

• ´ëÇѺñ´¢±â°úÇÐȸÁö   2001³â  42±Ç  8È£  788 ~ 794

• ½Å³ì°¢¼®¿¡¼­ EDAP LT-01 ¿Í Storz Modulith SLX¸¦ ÀÌ¿ëÇÑ Ã¼¿ÜÃæ°ÝÆļ⼮¼ú ´Üµ¶¿ä¹ýÀÇ ºñ±³

• Comparison of ESWL Monotherapy with EDAP LT-01 and Storz Modulith SLX for Staghorn Calculi

• Àӽ´ë/Seung Dea Lim

• ¼­ÀÏ¿µ/ÀÓÁ¤½Ä/Ill Young Seo/Joung Sik Rim

• ´ëÇѺñ´¢±â°úÇÐȸÁö   2001³â  42±Ç  8È£  781 ~ 787